 |
6-amino-5-chloro-N-[1R)-1-[5-[[[5-hloro-4-(trifluoromethyl)-2pyridinyl]amino]carbonyl]-2-thiazoyl]ethyl]-4-pyrimdinecarboxamide |
|---|---|
| Trade Name | |
| Orphan Indication | Stage IIb-IV melanoma |
| USA Market Approval | USA |
| USA Designation Date | 2013-10-15 00:00:00 |
| Sponsor | Millennium Pharmaceuticals, Inc.;40 Landsdowne Street;Cambridge, Massachusetts, 02139 |
